FILE:BMY/BMY-8K-20040628094749.txt.gz
EVENTS:	Financial statements and exhibits
TEXT:
ITEM: Financial statements and exhibits
================================================================================ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): June 28, 2004 BRISTOL-MYERS SQUIBB COMPANY (Exact Name of Registrant as Specified in its Charter) Delaware 1-1136 22-079-0350 (State or Other Jurisdiction (Commission File Number) (IRS Employer of Incorporation) Identification Number) 345 Park Avenue New York, NY 10154 (Address of Principal Executive Office) Registrant's telephone number, including area code: (212) 546-4000 ================================================================================
Item 5. OTHER EVENTS Incorporated by reference in its entirety is a press release issued by the Registrant on June 28, 2004, attached as exhibit 99.1, concerning the announcement today that it expects to increase its reserves for liabilities related to previously disclosed legal matters by approximately $400 million. These reserve increases are expected to be reflected as pre-tax charges to the Registrant's Company's earnings in the second quarter of 2004. Item 7(c) . EXHIBITS Exhibit 99.1 - Press release dated June 28, 2004, announcing that the Registrant expects to increase its reserves for liabilities by approximately $400 million for previously disclosed legal matters. SIGNATURE Under the requirements of the Securities Exchange Act of 1934, the Registrant has caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BRISTOL-MYERS SQUIBB COMPANY By: /s/ Sandra Leung ------------------------------------- Sandra Leung Secretary Dated: June 28, 2004
EXHIBIT INDEX Exhibit Number Description - ------- ----------------------------------------------------------------- 99.1 Press release dated June 28, 2004, announcing that the Registrant expects to increase its reserves for liabilities.

[LOGO] Bristol-Myers Squibb Company CONTACT: MEDIA: INVESTORS: Tracy Furey John Elicker 609-252-3208 212-546-3775 tracy.furey@bms.com john.elicker@bms.com Susan Walser 212-546-4631 susan.walser@bms.com BRISTOL-MYERS SQUIBB ANNOUNCES EXPECTED INCREASES IN LEGAL RESERVES OF $400 MILLION NEW YORK, NEW YORK (June 28, 2004) -- Bristol-Myers Squibb Company (NYSE: BMY) announced today that it expects to increase its reserves for liabilities related to previously disclosed legal matters by approximately $400 million. These reserve increases are expected to be reflected as pre-tax charges to the Company's earnings in the second quarter of 2004. Of the $400 million of expected increases, approximately $300 million relate to private litigation and governmental investigations related to wholesaler inventory issues and other accounting matters, increasing the reserve for those matters from $150 million to $450 million. The additional approximately $100 million of expected increases relates to product liability and other matters. The expected charges do not take into account any possible insurance recoveries. The expected charges for the second quarter are subject to further review in connection with the finalization of the Company's second quarter results. The Company is making this announcement today in connection with the expected effectiveness this week of its registration statements for outstanding debt securities in accordance with the terms of the Rule 144A offerings of those securities last year. -more-
-2- Eventual losses related to these matters may materially exceed the reserves, and the further impact of these matters could be material. For a discussion of the Company's legal proceedings, see Note 15--"Legal Proceedings and Contingencies" included in the Company's Quarterly Report on Form 10-Q/A for the period ended March 31, 2004. A detailed description of the private litigation and governmental investigations related to wholesaler inventory and other accounting matters and product liability matters is set forth in "Other Securities Matters" and "Product Liability Litigation", respectively, included in Note 15. Bristol-Myers Squibb is a global pharmaceutical and related health care products company whose mission is to extend and enhance human life. # # #


